Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): How can we improve outcomes in the near future?

Article ID	Journal	Published Year	Pages	File Type
10908962	Leukemia Research	2012	6 Pages	PDF

Keywords

Related Topics

Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research

Authors

Gordon L. Phillips,